Trexquant Investment LP Apellis Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$38.07 - $59.71 $5.68 Million - $8.91 Million	149,160 New	149,160 $5.72 Million
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $3.99 Million - $4.85 Million	51,988 New	51,988 $4.74 Million
Q2 2022 Aug 11, 2022	BUY	$35.07 - $59.21 $341,932 - $577,297	9,750 New	9,750 $441,000
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $322,226 - $716,698	-10,262 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$40.9 - $64.9 $213,170 - $338,258	5,212 Added 103.21%	10,262 $649,000
Q1 2021 May 13, 2021	BUY	$40.8 - $57.39 $206,040 - $289,819	5,050 New	5,050 $217,000
Q3 2020 Nov 06, 2020	SELL	$25.89 - $33.65 $445,023 - $578,409	-17,189 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$24.8 - $38.49 $212,263 - $329,435	8,559 Added 99.18%	17,189 $561,000
Q1 2020 May 08, 2020	BUY	$17.91 - $44.33 $154,563 - $382,567	8,630 New	8,630 $231,000

310

113M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.